Abstract | BACKGROUND AND PURPOSE: METHODS: RESULTS:
TNFR2 and COX-2 were upregulated and the release of PGE2 was promoted by TNF-β stimulation, which were all inhibited by Roflumilast. Roflumilast suppressed the promoted iNOS expression and NO production induced by TNF-β. MMP-3 and MMP-13 were up-regulated, and type 2 collagen was down-regulated by TNF-β stimulation, which were all reversed by Roflumilast. Roflumilast inhibited the promoted releasing of Interleukin-8 (IL-8) and Interleukin-12 (IL-12), expression of up-regulated NF-κB, and activation of NF-κB transcriptional activity induced by TNF-β. CONCLUSION:
|
Authors | Jingtong Zhao, Lian Duan, Renxiang Wang, Yi Liu, Jinlan Jiang |
Journal | Inflammation research : official journal of the European Histamine Research Society ... [et al.]
(Inflamm Res)
Vol. 69
Issue 12
Pg. 1191-1199
(Dec 2020)
ISSN: 1420-908X [Electronic] Switzerland |
PMID | 32990777
(Publication Type: Journal Article)
|
Chemical References |
- Aminopyridines
- Benzamides
- Collagen Type II
- Cyclopropanes
- Cytokines
- Lymphotoxin-alpha
- Phosphodiesterase 4 Inhibitors
- Receptors, Tumor Necrosis Factor, Type II
- Roflumilast
|
Topics |
- Aminopyridines
(pharmacology)
- Benzamides
(pharmacology)
- Cell Line
- Chondrocytes
(drug effects, metabolism)
- Collagen Type II
(metabolism)
- Cyclopropanes
(pharmacology)
- Cytokines
(metabolism)
- Extracellular Matrix
(drug effects)
- Humans
- Inflammation
(chemically induced, prevention & control)
- Lymphotoxin-alpha
- Phosphodiesterase 4 Inhibitors
(pharmacology)
- Receptors, Tumor Necrosis Factor, Type II
(metabolism)
- Signal Transduction
(drug effects)
|